PATENT CLAIM ANALYSIS

Application Number: 16086143
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["514", "252160"]

Abstract:
Provided herein are compositions and methods for treating or preventing metabolic disorders. In particular, provided herein are compositions, methods, and uses of Cyclin-dependent Kinase 6 (CDK6) inhibitors for treating and preventing metabolic diseases (e.g., type II diabetes, obesity, metabolic syndrome, elevated blood pressure, cardiovascular diseases, elevated fasting plasma glucose, and high serum triglycerides).

Claim (Index 1):
A method of treating or preventing metabolic disease in a subject, comprising:\n administering a CDK6 inhibitor to said subject.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 97.0
- Lexical Diversity: 1.60465
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14778379', '13698385', '14021825', '14389374', '14376209']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7514006938528434
- 35 USC 102 Novelty (BERT): 0.5015464140452804
- Combined Prediction Score: 0.7264152658720872
- Mean Citation Score: 237.85321
- Max Citation Score: 250.6277
- Similarity Product: 177.4852398011327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test